Chondrosarcomas of the larynx and sinus maxillaris – review of literature and report of three cases
Journal Title: Otolaryngologia Polska - Year 2009, Vol 63, Issue 3
Abstract
Chondrosarcoma is a very rare neoplasm in the head and neck region. This region is associated with favourable prognosis. Only 340 cases of chondrosarcoma of the larynx and nearly 300 of sinus maxillaris have been reported in this localization. The most reasonable treatment is radical surgery. Radiotherapy and chemotherapy are of little value. Without metastasis the long term prognosis is excellent. Clinical, pathologic and radiologic characterities of these tumors are described and review of the literature is presented. The authors present two cases chondrosarcoma of the larynx and one case chondrosarcoma of sinus maxillaries.
Authors and Affiliations
Tatiana Gierek, Wojciech Smółka, Jarosław Paluch
Cytokiny w popłuczynach z zatok szczękowych jako wykładnik stanu zapalnego
Introduction. In a pathogenetic chain of chronic sinusitis there is a set of cellular and humoral factors that are accepted as characteristic of a chronic inflammatory process. These include mast cells, granulocytes (bas...
Epidemiological and demographic analysis of indications for Baha® surgery in Poland - multicenter study
Aim of the study: To collect and analyze epidemiological and demographical data of patients qualified for and implanted with the Baha® system in Poland. Material and method: 17 out of 28 otolaryngology departments perfor...
Neoplastic tumors in patients with unilateral inflammations qualified for endoscopic surgery
Introduction: The aim of this work was to analyze the occurrence and type of neoplasm in unilateral pathological lesions within the nose and paranasal sinuses in patients who underwent endoscopic surgery, in own material...
Retrospektywna analiza przyczyn niepowodzeń w leczeniu nowotworów jamy ustnej i gardła w Klinice Otolaryngologii i Onkologii Laryngologicznej Uniwersytetu Medycznego w Poznaniu w latach 2000–2005
Wstęp<br/><br/>
Rola karbocysteiny w leczeniu zapaleń zatok przynosowych